Literature DB >> 7583523

Involvement of blood coagulation factor XIII in burn healing in the carbon tetrachloride-induced hepatic injury model in rats.

T Ogawa1, Y Morioka, T Inoue, M Takano, S Tsuda.   

Abstract

An involvement of blood coagulation factor XIII (FXIII) in healing of burns was examined in rats with the carbon tetrachloride (CCl4)-induced hepatic injury. The oral administration of 2 and 4 ml/kg CCl4 to rats every 4 days delayed healing of the burns induced on the back skin and decreased FXIII activity. These animals showed some hepatotoxic signs (increased glutamic-oxaloacetic and glutamic-pyruvic transaminases) and accelerated blood coagulation system (increased fibrino-peptide A and fibrin degradation product). The delay in the burn healing was shortened by repeated intravenous injections with normal human placenta-derived FXIII concentrate (Fibrogammin P; 120 U/body) every 4 days. There was a negative correlation between plasma FXIII activity at the end of experiment and the time required for wound healing. These findings suggest that reduction in FXIII activity may be one of the factors inducing delayed wound healing in the CCl4-induced hepatic injury rats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583523     DOI: 10.1007/BF01782980

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  8 in total

1.  On the Solubility of Fibrin Clots.

Authors:  K Laki; L Lóránd
Journal:  Science       Date:  1948-09-10       Impact factor: 47.728

2.  Wound healing at the site of microvascular anastomosis: fibrin-stabilizing factor XIII administration and its effects.

Authors:  N Isogai; Y Ueda; N Kurozumi; H Kamiishi
Journal:  Microsurgery       Date:  1990       Impact factor: 2.425

3.  [Effect of carbon tetrachloride on blood coagulation and fibrinolytic activities in rats].

Authors:  K Sakamoto; K Otsuka; T Kasahara; K Abe
Journal:  Nihon Yakurigaku Zasshi       Date:  1986-10

4.  The role of factor XIII in fibroblast proliferation.

Authors:  M Ueyama; T Urayama
Journal:  Jpn J Exp Med       Date:  1978-04

5.  [Hepatic fibrosis and coagulation factor XIII].

Authors:  S Iwabuchi
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1983-10

6.  Growth regulation of fibroblasts by thrombin, factor XIII and fibronectin.

Authors:  H D Bruhn; J Pohl
Journal:  Klin Wochenschr       Date:  1981-02-02

7.  Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor.

Authors:  D F Mosher
Journal:  J Biol Chem       Date:  1975-08-25       Impact factor: 5.157

8.  Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.

Authors:  Y Sakata; N Aoki
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

  8 in total
  5 in total

1.  [Coagulation factor XIII: more than just a fibrin stabilizer].

Authors:  N Messaoudi; F Lamaalmi; M Chakour; A Belmekki; M Naji
Journal:  Ann Burns Fire Disasters       Date:  2011-03-31

2.  Systemic and intestinal levels of factor XIII-A: the impact of inflammation on expression in macrophage subtypes.

Authors:  Christoffer Soendergaard; Peter Helding Kvist; Jakob Benedict Seidelin; Hermann Pelzer; Ole Haagen Nielsen
Journal:  J Gastroenterol       Date:  2015-12-11       Impact factor: 7.527

3.  Dynamics of coagulation factor XIII activity after video-assisted thoracoscopic lobectomy for non-small cell lung cancer.

Authors:  Suguru Shirai; Yoshikane Yamauchi; Fumi Yokote; Takashi Sakai; Yuichi Saito; Yukinori Sakao; Masafumi Kawamura
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

4.  Clinical value of exogenous factor XIII for prolonged air leak following pulmonary lobectomy: a case control study.

Authors:  Hidetoshi Inoue; Noritoshi Nishiyama; Shinjiro Mizuguchi; Koshi Nagano; Nobuhiro Izumi; Hiroaki Komatsu; Shigefumi Suehiro
Journal:  BMC Surg       Date:  2014-12-15       Impact factor: 2.102

5.  Nonclinical analysis of the safety, pharmacodynamics, and pharmacokinetics of plasma-derived human FXIII concentrate in animals.

Authors:  Andrea Beyerle; Cristina Solomon; Gerhard Dickneite; Eva Herzog
Journal:  Pharmacol Res Perspect       Date:  2016-03-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.